These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 3494170)

  • 1. Haemodialysis-membrane-induced phagocyte oxidative metabolism activation and interleukin-1 production.
    Descamps-Latscha B; Herbelin A; Nguyen AT; Uzan M; Zingraff J
    Life Support Syst; 1986; 4(4):349-53. PubMed ID: 3494170
    [No Abstract]   [Full Text] [Related]  

  • 2. Acute and chronic influence of hemodialysis according to the membrane used on phagocytic function of neutrophils and monocytes and pro-inflammatory cytokines production in chronic renal failure patients.
    Muniz-Junqueira MI; Braga Lopes C; Magalhães CA; Schleicher CC; Veiga JP
    Life Sci; 2005 Nov; 77(25):3141-55. PubMed ID: 16005905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of polysulfone and hemophan hemodialysis membranes on phagocytes.
    Kubala L; Cíz M; Soska V; Cerný J; Lojek A
    Gen Physiol Biophys; 2002 Dec; 21(4):367-80. PubMed ID: 12693710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of hemodialysis (HD) membranes on interleukin 1-beta (IL-1 beta) production from peripheral blood mononuclear cells (PBMC).
    Momoi T; Ono M; Takagi T; Sugiura S; Ogawa H; Saito A
    Clin Nephrol; 1995 Nov; 44 Suppl 1():S24-8. PubMed ID: 8608657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mediators of complement-independent granulocyte activation during haemodialysis: role of calcium, prostaglandins and leukotrienes.
    Böhler J; Donauer J; Birmelin M; Schollmeyer PJ; Hörl WH
    Nephrol Dial Transplant; 1993; 8(12):1359-65. PubMed ID: 8159305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complement activation and leucopenia on cellulosic haemodialyzers: influence of the membrane area and role of hydroxyl moieties.
    Goldman M; Lietaer N; Lambert P; Thayse C; Vanherweghem JL
    Life Support Syst; 1987; 5(4):317-22. PubMed ID: 3501504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemodialysis membrane-induced activation of phagocyte oxidative metabolism detected in vivo and in vitro within microamounts of whole blood.
    Nguyen AT; Lethias C; Zingraff J; Herbelin A; Naret C; Descamps-Latscha B
    Kidney Int; 1985 Aug; 28(2):158-67. PubMed ID: 3834227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Haemodialysis membranes modulate chronically the production of TNF alpha, IL1 beta and IL6.
    Mege JL; Olmer M; Purgus R; Bertocchio P; Farnarier C; Kaplanski S; Capo C; Bongrand P
    Nephrol Dial Transplant; 1991; 6(11):868-75. PubMed ID: 1775252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Challenge of phagocyte metabolism by extracorporeal circulation and membrane contact. A biocompatibility test.
    Vanholder RC; Dhondt A; Ringoir SM
    ASAIO Trans; 1988; 34(3):543-5. PubMed ID: 3143383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abnormal leucocyte locomotion induced by haemodialysis membranes. A clue to dialysis leucopenia.
    Losito A; Buoncristiani U; Cecchini C
    J Clin Lab Immunol; 1983 Feb; 10(2):87-90. PubMed ID: 6601717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitation of membrane biocompatibility.
    Colton CK
    Contrib Nephrol; 1987; 59():110-25. PubMed ID: 3502085
    [No Abstract]   [Full Text] [Related]  

  • 12. Leucopenia, hypoxia and complement activation in haemodialysis. Three unrelated phenomena.
    de Vinuesa SG; Resano M; Luño J; Gonzalez C; Barril G; Junco E; Valderrabano F
    Proc Eur Dial Transplant Assoc; 1983; 19():159-67. PubMed ID: 6878230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparison of biocompatibility of hemophane, cellulose diacetate and acrilonitile membranes in hemodialysis].
    Germin Petrović D
    Acta Med Croatica; 2004; 58(1):31-6. PubMed ID: 15125391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of interleukin-1 during hemodialysis.
    Haeffner-Cavaillon N; Jahns G; Poignet JL; Kazatchkine MD
    Kidney Int Suppl; 1993 Jan; 39():S139-43. PubMed ID: 8468916
    [No Abstract]   [Full Text] [Related]  

  • 15. Evaluation of phagocytic cell function in an ex vivo model of hemodialysis.
    Ward RA; Schmidt B; Blumenstein M; Gurland HJ
    Kidney Int; 1990 Feb; 37(2):776-82. PubMed ID: 2407889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myeloperoxidase serves as a marker of oxidative stress during single haemodialysis session using two different biocompatible dialysis membranes.
    Wu CC; Chen JS; Wu WM; Liao TN; Chu P; Lin SH; Chuang CH; Lin YF
    Nephrol Dial Transplant; 2005 Jun; 20(6):1134-9. PubMed ID: 15814542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [C-reactive protein (CRP) as a marker of of hemodialysis biocompatibility].
    Szepietowski T; Krajewska M
    Polim Med; 1997; 27(1-2):47-59. PubMed ID: 9380601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms and consequences of complement activation during hemodialysis.
    Kazatchkine MD; Haeffner-Cavaillon N
    Adv Exp Med Biol; 1989; 260():19-26. PubMed ID: 2624243
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical characterization of Dicea a new cellulose membrane for haemodialysis.
    Hoenich NA; Woffindin C; Cox PJ; Goldfinch M; Roberts SJ
    Clin Nephrol; 1997 Oct; 48(4):253-9. PubMed ID: 9352161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antioxidants and malondialdehyde during hemodialysis with cellulose diacetate and polysulfone membranes].
    Eiselt J; Racek J; Holecek V; Krejcová I; Opatrný K
    Cas Lek Cesk; 1996 Nov; 135(21):691-4. PubMed ID: 8998818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.